SunTrust Robinson analyst David S Macdonald reiterated a Hold rating on Mednax Inc (MD) on November 5 and set a price target of $44. The company’s shares closed yesterday at $39.48, close to its 52-week low of $37.26.
According to TipRanks.com, Macdonald is a 5-star analyst with an average return of 16.1% and a 73.9% success rate. Macdonald covers the Services sector, focusing on stocks such as American Renal Associates Holdings Inc, Walgreens Boots Alliance, and WellCare Health Plans.
Mednax Inc has an analyst consensus of Moderate Buy, with a price target consensus of $46.18, a 17.0% upside from current levels. In a report issued on November 1, Robert W. Baird also maintained a Hold rating on the stock with a $40 price target.
.
See today’s analyst top recommended stocks >>
The company has a one-year high of $63.04 and a one-year low of $37.26. Currently, Mednax Inc has an average volume of 830.1K.
Based on the recent corporate insider activity of 35 insiders, corporate insider sentiment is negative on the stock.
TipRanks has tracked 36,000 company insiders and found that a few of them are better than others when it comes to timing their transactions. See which 3 stocks are most likely to make moves following their insider activities.
MEDNAX, Inc. provides physician services including newborn, anesthesia, maternal-fetal, tele radiology, pediatric cardiology and other pediatric subspecialty care. The company’s solution include anesthesiology & pain management, prenatal, neonatal, pediatric, radiology, tele radiology, revenue cycle management and perioperative improvement consulting.
